Gilead (GILD.US) has received approval for the long-acting HIV treatment "Lenacapavir" to be marketed in China.
The official NMPA website shows that Gilead's (GILD.US) HIV therapy, Lenacapavir tablets and Lenacapavir injection, has received marketing approval.
Is Gilead Sciences, Inc. (GILD) the Best Pharma Dividend Stocks to Buy In 2024?
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Morgan Stanley: Personalized cancer vaccines and ADCs will become the main catalysts in the oncology treatment Industry by 2025.
Morgan Stanley stated in a recent research report that personalized cancer vaccines and antibody-drug conjugates (ADCs) will become one of the major innovations in cancer biotechnology next year.
Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
